236 related articles for article (PubMed ID: 18683750)
1. [Clinical review of 97 patients with endometrial stromal sarcoma].
Li N; Wu LY; Zhang HT; An JS; Li XG; Ma SK
Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):115-9. PubMed ID: 18683750
[TBL] [Abstract][Full Text] [Related]
2. Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expression.
Geller MA; Argenta P; Bradley W; Dusenbery KE; Brooker D; Downs LS; Judson PL; Carson LF; Boente MP
Gynecol Oncol; 2004 Dec; 95(3):632-6. PubMed ID: 15581975
[TBL] [Abstract][Full Text] [Related]
3. Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients.
Bodner K; Bodner-Adler B; Obermair A; Windbichler G; Petru E; Mayerhofer S; Czerwenka K; Leodolter S; Kainz C; Mayerhofer K
Gynecol Oncol; 2001 May; 81(2):160-5. PubMed ID: 11330943
[TBL] [Abstract][Full Text] [Related]
4. Treatment options in stage I endometrial stromal sarcoma: a retrospective analysis of 53 cases.
Li N; Wu LY; Zhang HT; An JS; Li XG; Ma SK
Gynecol Oncol; 2008 Feb; 108(2):306-11. PubMed ID: 18061249
[TBL] [Abstract][Full Text] [Related]
5. A multi-institutional review of outcomes of endometrial stromal sarcoma.
Leath CA; Huh WK; Hyde J; Cohn DE; Resnick KE; Taylor NP; Powell MA; Mutch DG; Bradley WH; Geller MA; Argenta PA; Gold MA
Gynecol Oncol; 2007 Jun; 105(3):630-4. PubMed ID: 17320937
[TBL] [Abstract][Full Text] [Related]
6. Outcome and prognostic factors in endometrial stromal tumors: a Rare Cancer Network study.
Schick U; Bolukbasi Y; Thariat J; Abdah-Bortnyak R; Kuten A; Igdem S; Caglar H; Ozsaran Z; Lössl K; Schleicher U; Zwahlen D; Villette S; Vees H
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):e757-63. PubMed ID: 22300565
[TBL] [Abstract][Full Text] [Related]
7. Stages I to II WHO 2003-defined low-grade endometrial stromal sarcoma: how much primary therapy is needed and how little is enough?
Feng W; Hua K; Malpica A; Zhou X; Baak JP
Int J Gynecol Cancer; 2013 Mar; 23(3):488-93. PubMed ID: 23435438
[TBL] [Abstract][Full Text] [Related]
8. [Treatment and prognosis of low-grade malignant endometrial stromal sarcoma].
Ma SK; Zhang HT; Wu LY; Liu LY; Li B
Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):74-8. PubMed ID: 17575701
[TBL] [Abstract][Full Text] [Related]
9. Endometrial stromal sarcomas--a retrospective analysis of 11 patients.
Diesing D; Cordes T; Finas D; Löning M; Mayer K; Diedrich K; Friedrich M
Anticancer Res; 2006; 26(1B):655-61. PubMed ID: 16739335
[TBL] [Abstract][Full Text] [Related]
10. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
Ma SK; Zhang HT; Sun YC; Wu LY
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
[TBL] [Abstract][Full Text] [Related]
11. Surgery and adjuvant radiation therapy of endometrial stromal sarcoma.
Weitmann HD; Kucera H; Knocke TH; Pötter R
Wien Klin Wochenschr; 2002 Jan; 114(1-2):44-9. PubMed ID: 12407935
[TBL] [Abstract][Full Text] [Related]
12. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
13. Low-grade and high-grade endometrial stromal sarcoma: A National Cancer Database study.
Seagle BL; Shilpi A; Buchanan S; Goodman C; Shahabi S
Gynecol Oncol; 2017 Aug; 146(2):254-262. PubMed ID: 28596015
[TBL] [Abstract][Full Text] [Related]
14. Endometrial stromal sarcoma-A retropsective analysis of factors affecting recurrence.
Agarwal R; Rajanbabu A; Nair IR; Satish C; Jose G; Unikrishnan UG
Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():92-97. PubMed ID: 28738297
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors, treatment and outcome in a Turkish population with endometrial stromal sarcoma.
Donertas A; Nayki U; Nayki C; Ulug P; Gultekin E; Yildirim Y
Asian Pac J Cancer Prev; 2015; 16(3):881-7. PubMed ID: 25735377
[TBL] [Abstract][Full Text] [Related]
16. Endometrial stromal sarcoma: analysis of treatment failures and survival.
Gadducci A; Sartori E; Landoni F; Zola P; Maggino T; Urgesi A; Lissoni A; Losa G; Fanucchi A
Gynecol Oncol; 1996 Nov; 63(2):247-53. PubMed ID: 8910635
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors and outcome in women with uterine sarcoma.
Denschlag D; Masoud I; Stanimir G; Gilbert L
Eur J Surg Oncol; 2007 Feb; 33(1):91-5. PubMed ID: 17174517
[TBL] [Abstract][Full Text] [Related]
18. Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer.
Papanikolaou A; Kalogiannidis I; Goutzioulis M; Misailidou D; Makedos A; Vergote I; Makedos G
Arch Gynecol Obstet; 2006 May; 274(2):91-6. PubMed ID: 16518607
[TBL] [Abstract][Full Text] [Related]
19. Analysis of failures in patients with FIGO stage IIIc1-IIIc2 endometrial cancer.
Gadducci A; Cosio S; Fabrini MG; Guerrieri ME; Greco C; Genazzani AR
Anticancer Res; 2012 Jan; 32(1):201-5. PubMed ID: 22213308
[TBL] [Abstract][Full Text] [Related]
20. The long-term survival of women with surgical stage II endometrioid type endometrial cancer.
Ayhan A; Taskiran C; Celik C; Yuce K
Gynecol Oncol; 2004 Apr; 93(1):9-13. PubMed ID: 15047207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
